Medicine guide
Lumark
·
- Prescription status not stated
- Everything that fits nowhere else, such as contrast media
- Active substance
- Lutetium (177Lu) chloride
- Made by
- I.D.B. Radiopharmacy B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Lumark is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | I.D.B. Radiopharmacy B.V. |
|---|---|
| Active substance | Lutetium (177Lu) chloride |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V10 · Everything that fits nowhere else, such as contrast media |
| Authorised on | 2015-06-18 |
| Last updated by the regulator | 2026-02-11 |
| EMA product number | EMEA/H/C/002749 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
TheralugandEU authorisation Eckert & Ziegler Radiopharma GmbH · Lutetium (177Lu) chloride · V10XEndolucinBetaEU authorisation ITM Medical Isotopes GmbH · Lutetium (177Lu) chloride · V10XIlumiraEU authorisation Shine Europe B.V. · Lutetium (177Lu) chloride · V10XLutetium (177Lu) chloride Billev (previously Illuzyce)EU authorisation Billev Pharma Aps · Lutetium (177Lu) chloride · V10X